Opportunity Analysis for Biosimilars - South Korea
Opportunity Analysis for Biosimilars - South Korea
Patent Expiry of Biologics to Provide Potential Growth for Biosimilars
RELEASE DATE
05-Sep-2012
05-Sep-2012
REGION
Asia Pacific
Asia Pacific
Research Code: P601-01-00-00-00
SKU: HC02369-AP-MR_08491
$4,950.00
In stock
SKU
HC02369-AP-MR_08491
Description
This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.
Table of Contents
Opportunity Analysis
- South Korea Biosimilars Market
This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.
No Index | No |
---|---|
Podcast | No |
Author | Poornima Srinivasan |
Industries | Healthcare |
WIP Number | P601-01-00-00-00 |
Is Prebook | No |